L M Ott et al
Electrospun scaffolds have gained attention for their biomimetic fibrous microenvironment and relative ease of fabrication. These materials have excellent potential for tracheal application, as they are easily shaped into tubular structures for circumferential applications or into sheets for segmental patch applications. Degradable polymers were chosen for their lack of reliance on donor tissues and ability to be replaced and regenerated by host tissue. Our scaffolds are designed into a graded bilayer with one layer providing long-term structural support (i.e. polycaprolactone (PCL)) and the other layer allowing for short-term tissue ingrowth and drug delivery (i.e. poly(lactic-co-glycolic acid) (PLGA)). A 3D printed polymeric ring of PCL was incorporated into the fibrous scaffold for added structural integrity. In the current study, seven different permutations of the scaffold were tested, (1) PCL alone, (2) PLGA alone, (3) PCL/PLGA co-spun, (4) PCL/PLGA blend, (5) PCL/ PLGA bilayer, (6) PCL/PLGA graded bilayer, and (7) PCL/PLGA graded bilayer with incorporated rings. The porosity, fiber morphology, molecular weight, mass loss, and mechanical properties of these scaffolds were evaluated over time in hydrated conditions at 37 °C (figure 1). Characterization of properties over time is crucial for scaffold design and pre-clinical data collection. The purpose of the current study is to characterize the tracheal scaffolds and determine the designs that sufficiently meet physiological requirements to maintain a patent airway. Cell response to the materials was not assessed in this study, however, the polymeric materials have been widely used in biomedical applications and in vivo data is available [8] . We hypothesized that the PLGA would affect porosity and mass loss/molecular weight properties, that the PCL component would provide stability of properties over time, and that the ring would dramatically improve mechanical performance.
Materials and methods

Material fabrication
Using a custom designed electrospinning apparatus, 2 mm thick electrospun hollow cylinders were fabricated following a slightly modified protocol established previously by our group [8, 9] . A 7 wt% polycaprolactone (PCL; inherent viscosity 1.0-1.3 dl g −1 , LACTEL, Birmingham, AL) solution in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP; Oakwood Chemical; Columbia, SC) was mixed with a 14 wt% poly(D,L-lactide-co-glycolic acid) copolymer (PLGA; 50:50 D, L-lactide: glycolide, acid end group, inherent viscosity 0.35 dl g −1 , Evonik Industries, Birmingham, AL) solution in HFIP. The solutions were placed in 20 ml syringes and fitted into programmable syringe pumps (PhD Ultra, Harvard Apparatus, Holliston, MA) set to extrude the solution at 5 ml h −1 . As the solution was extruded through a charged 20 gauge needle (+12 kV; Glassman High Voltage, High Bridge, NJ), the charged polymer was drawn from the needle tip (10-15 cm) to a negatively charged (−6 kV) rotating cylindrical stainless steel mandrel (7 mm diameter), with a distance of approximately 15 cm between the needle and cylinder surface.
To create the monolayer groups (figure 1), 40 ml of PCL solution and 40 ml of PLGA solution were electrospun to create the PCL monolayer and PLGA mono layer groups, respectively. The PCL/PLGA cospun monolayer group was created by electrospinning separate solutions of 20 ml of PCL and 20 ml of PLGA at the same time from opposite sides of the mandrel, simultaneously, collecting both fiber types on the mandrel. The PCL/PLGA blend monolayer group was created by mixing equal volumes (20 ml each) of 7 wt% PCL and 14 wt% PLGA solutions prior to electrospinning (creating a 3.5 wt% PCL and 7 wt% PLGA solution for a total polymer solution of 10.5 wt%).
To create the bilayer group, 20 ml of PCL solution was electrospun onto the mandrel followed by 20 ml of PLGA solution.
To create the gradient interface group, 12 ml of PCL was deposited, followed by co-spinning 8 ml of PCL and 8 ml of PLGA from two different needles on opposite sides of the mandrel to create the interface layer, followed by 12 ml of PLGA.
To create the 3D printed rings, a 3D CAD image was used to print 7 mm ID, 11 mm OD, 2 mm thick PCL (MP05188, MakerBot filament, Brooklyn, NY) rings with a circular cross section (RepRapPro printer, Briston, UK).
To create the gradient interface group with circumferential rings, 6 ml of PCL solution was electrospun onto the mandrel, the PCL rings were placed onto the PCL scaffold at 3-4 mm intervals, 6 ml of PCL solution was electrospun over the rings, followed by co-spinning 8 ml of PCL solution and 8 ml of PLGA solution to create the interface layer, followed by 12 ml of PLGA solution.
If electrospinning was stopped for more than 5 min, HFIP was lightly misted with an atomizer (Z190373, Sigma, Milwaukee, WI) onto the outer surface of the scaffold to prepare the surface for the next layer. This was done to prevent delamination of the layers. Once the 2 mm wall thickness was achieved, the electrospun tube was removed from the collecting rod, lyophilized for 24 h, sterilized using ethylene oxide, and aired in a fume hood for 24 h.
Degradation conditions
Following ASTM F1635-11, the scaffolds were degraded in simulated physiological conditions. Scaffolds were immersed in phosphate-buffered saline (PBS; P5386, Sigma, St. Louis, MO) at 7.4 ± 0.2 at 37 °C. To maintain stable aging conditions, the PBS-to-scaffold volume ratio was 100:1. The pH was measured periodically and if an excursion beyond the specified pH range occurred the PBS was removed and refreshed with new PBS for all samples. Samples were collected and washed at specific time points (0, 1, 2, 3, 4, 6, or 12 weeks) for analysis.
Scanning electron microscopy (SEM)
All scaffolds were lyophilized overnight before being cut with a scalpel and placed on a specimen holder. The samples were sputter coated (Q150T ES, Quorum Technologies, East Sussex, England) with 30 nm of gold before being positioned in the SEM (Leo 1550 field emission, Carl Zeiss, Oberkochen, Germany).
The samples were subsequently placed under high vacuum at an accelerating voltage of 10 kV and working distance between 11.5-12.5 mm using the SE2 detector. Each sample was imaged at 500×, 1500×, 2500×, and 5000 × magnification with a line integration time of 45 s. Fibers were selected randomly and the diameter was measured and recorded.
Porosity
Porosity calculation was determined using the gravimetric method. The mass of the sample was measured (scale ± 0.0001 g), followed by the inside diameter, outside diameter, and height (calipers ± 0.01 mm). Using this information, the apparent density and porosity were calculated according to the equation: ρ app = 4 m/πd 2 h, Porosity (%) = (1 − ρ app /ρ) × 100, with m, d, h, and ρ as the mass, diameter, height, and bulk density, respectively [10] . The bulk density (ρ) of PCL and PLGA were 1.081 ± 0.003 gm cc −1 and 1.324 ± 0.004 gm cc −1 , respectively.
Mass loss
The mass loss was determined from the initial mass before degradation and the residual mass after rinsing with distilled water and lyophilizing. The results were reported as a percent mass loss versus degradation time.
Size exclusion chromatography
The residual mass of each scaffold completely dissolved in chloroform (at 5 mg ml −1 ) and filtered with a 0.02 μm filter (6809-2002; Whatman; Buckinghamshire, UK). An HPLC system (CBM-20A, LC-20AB, SIL-10AF, CTO-20AC; Shimadzu; Kyoto, Japan) equipped with a column (PL1110-1520, PL1110-6504 (rated for 200-400 000 g mol −1 ); polystyrene/divinylbenzene matrix packing, Agilent Technologies; Santa Clara, CA) and multi-angle light scattering (MALS) (miniDAWN TREOS; Wyatt Technology; Santa Barbara, CA) and refractive index (RI) (RID-10A; Shimadzu; Kyoto, Japan) detectors was used. Samples were eluted at 1 ml min −1 and the column was maintained at 35 °C. A series 
poly(lactic-co-glycolic acid) (PLGA)-only, (3) co-spun, (4) blend, (5) bilayer, (6) gradient, (7) gradient + rings. Scaffolds were aged for 12 weeks and the scaffold morphology, degradation, porosity, and mechanical properties were evaluated. (SEM-scanning electron microscopy, SEC-size exclusion chromatography).
of narrow polydispersity polystyrene standards were used for calibration. After data collection, the RI and MALS data were analyzed for weight average molecular weight (M w ) and number average molecular weight (M n ) values. MALS data was analyzed with light scattering equations and Zimm plots using ASTRA 5 software (Wyatt) [11] . The dn/dc values for PCL and PLGA were empirically determined using the RI detector (RID-10A; Shimadzu; Kyoto, Japan) (PCL = 0.0386 ± 0.0047 ml g −1 , PLGA = 0.0243 ± 0.0025 ml g −1 ). RI data were analyzed with the polystyrene calibration curve using LC Solutions software (Shimadzu). The MarkHouwink-Sakurada correction was not performed because the a and K constants for PCL and PLGA were not available in the literature [12] . Dispersity (Ð) was calculated using the RI data by dividing the weight average molecular weight (M w ) by the number average molecular weight (M n ), i.e. Ð = M w /M n . Ð values were categorized into uniform monodisperse (Ð = 1), narrow monodisperse (Ð = 1.0-1.1), moderate polydisperse (Ð = 1.1-2.0), and broad polydisperse (Ð > 2.0).
Tensile testing
The testing method is similar to a previously published study from our group [13] . Briefly, tensile tests were performed using a uniaxial testing apparatus (Instron Model 5848, Canton, MA) with a custom-made stainless steel bath and grip assembly.
Prior to degradation, the specimens were cut into long rectangular strips from the tubular scaffolds, in a circumferential direction. Prior to testing, the specimens were cut into 2 mm width strips using parallel razor blades. The mean specimen thickness was 1.26 ± 0.39 mm and the mean width was 1.96 ± 0.16 mm. Specimen dimensions were measured using calipers (±0.01 mm). After specimens were secured between the grips, a tare load of 0.03 N was applied to remove the laxity of the specimen. The bath was then filled with PBS at 37 °C and the specimen was allowed to re-equilibrate under this tare load for 10 min. The mean initial specimen length was 7.6 ± 1.0 mm. Preliminary studies determined that preconditioning was not required to obtain repeatable stress-strain curves and that a stress relaxation phase of 30 min was sufficient for the samples to reach equilibrium. Preliminary testing showed that 15% strain was safely below the onset of failure or slippage from grips (as indicated by sudden drops in force during step strain).
A buoyant force correction was performed as described by Detamore and Athanasiou [14] . Briefly, the load exerted by the PBS on the top grip (F b ) was measured empirically as a function of grip-to-grip separation (d). The measured force (F m ) was adjusted to the actual force experienced by the sample (F) by subtracting the effect of buoyancy, i.e.
, where L 0 is the initial specimen length. For a consistent buoyant profile, the bath height was held constant throughout all experiments and the bath was covered with parafilm to reduce evaporation. The change in bath height was observed to be negligible at the end of each test.
The testing protocol involved two phases: (1) applying a tensile load of 1% strain s −1 to a 15% strain endpoint and (2) holding for 30 min at 15% strain. Stress-strain curves were generated from the continuous pull during the step strain to 15%. Young's moduli were obtained from the linear regions of the stressstrain curves (no toe region observed). Equilibrium moduli were obtained by dividing the mean stress during the last 30 s of the relaxation phase by the step strain (15%).
Burst pressure
In accordance with ISO 7198:1998(E) and a previously published method [15] , 60 ml syringe (BectonDickenson, USA) was filled with water and placed in a syringe pump (KD Scientific, USA) set to run at a constant rate of 20 ml min −1
. The syringe was attached to a length of surgical tubing, which was attached to a custom pressure sensor. This pressure sensor was attached to another length of surgical tubing, which in turn was connected to a pediatric Foley catheter (Coloplast, Denmark). The catheter's balloon was placed in the view field of a High Accuracy CCD Micrometer (Keyence, USA). Pressure and scaffold diameter readings were measured and recorded at time intervals of 0.25 s as the tests took place using Labview 2010 software.
After test completion, the pressure and width of the scaffold were monitored and recorded. The syringe pump was deactivated and testing ceased when the scaffold failed or the pressure reached 30 psig. The maximum pressure of 30 psig was chosen based on the physical constraints of the catheter, tubing connections, and syringe pump. The average change in diameter at 30 psig or failure of each group at the 0, 3, 6, and 12 week time points was calculated and recorded.
Suture retention
Suture retention tests were performed using a uniaxial testing apparatus (Instron Model 3342, Canton, MA) with a custom-made suture fixture (a hook attached to the top fixture). The specimen geometry was elliptical with a 2.5 cm length and 1 cm width. The elliptical shaped specimens were cut in half using a scalpel, so that the specimens were 1.25 cm length and 1 cm width. Specimens were oriented in the bottom grip in such a way that testing was done in two directions to simulate the suture forces in the radial and longitudinal direction. Specimen dimensions were measured using a caliper (±0.01 mm). The mean specimen thickness was 1.67 ± 0.71 mm. A 4-0 PDS suture (M315A; Patterson Veterinary; Devens, MA) was placed 3 mm from the edge of the scaffold, tied into a loop and knotted seven times. The suture loop was attached to the suture holder and testing commenced. The testing protocol involved pulling the suture loop at 1% strain s −1 (with the strain based on the length between bottom grip and the suture hole) until the sutured pulled through the scaffold (no tare load applied as the only measurement obtained was the final force). The testing was not done under hydrated conditions as the scaffold was pre-hydrated and testing time was short enough to ensure that the specimen remained hydrated during testing. The force required to pull the suture through the scaffold was classified as the suture holding capacity (SHC) and the SHC divided by the scaffold thickness multiplied by the suture thickness was classified as the suture retention strength (SRS) [16] .
Tube flattening
Unconfined compression testing was performed using a uniaxial testing apparatus (Instron Model 5848, Canton, MA) with a custom-made stainless steel bath and compressive platen assembly.
Specimen dimensions were measured using a caliper (±0.01 mm). The specimen geometry was tubular with a 21.0 ± 1.7 mm length and a mean inner diameter of 6.5 ± 1.3 mm and mean outer diameter of 9.6 ± 1.6 mm. The specimens were placed on the bottom platen and a tare load of 0.1 N was applied. The bath was filled with PBS at 37 °C and the specimen was allowed to re-equilibrate under this tare load for 10 min. Then the specimen was compressed in the radial direction at 0.1667% strain s −1 until reaching 80% strain (based on outer diameter) or until the load reached 45 N. The buoyant force was empirically determined to be negligible, a result of the top platen having a smaller volume and shorter distance traveled as compared to the tensile testing grips, resulting in a smaller buoyant force change as the fixture traveled through the PBS. To account for specimen recovery, the sample outer radii were measured 1 h after testing.
The tube flattening force at 100% strain (for inner diameter) was determined by examining the loadextension profile, where the scaffold compression region was linear and deviated from linearity at the point of flattening (100% strain based on inner diameter). After the point of flattening, the load-extension profile exponentially increased as force from the bottom platen overtook the measured load. To isolate the point of flattening, a linear regression of the compression region was established and the point of flattening was established to be at 15% deviation. 15% deviation represented a reasonable approach to allow a reproducible value and objective basis for identification of flattening. As a check, the extension at this point was compared to the caliper measured inner diameter to ensure a reasonable value had been identified. The actual caliper measurement was not used because the 100% strain could not be accurately determined by caliper measurements, due to difference in caliper and extension measurements after tare load. Percent recovery was determined by taking a ratio of the pre-and post-test outer diameter based on caliper measurement.
Statistical analysis
Using one-way ANOVA and Tukey's post-hoc analysis for SEM fiber diameter, porosity, Young's modulus, equilibrium modulus, burst pressure diameter change, SRS, tube flattening force, and tube recovery differences were determined to be significant if p < 0.05.
Results
Gross morphology
Gross morphological images of scaffolds were collected through the course of degradation (0, 1, 2, 3, 4, 6, and 12 weeks) (figure 2). The PCL component of the scaffolds was preserved through the course of 12 weeks, while the PLGA layer degraded (to a point that it could not be extracted from a tube) between 2 and 3 weeks (PLGAonly). The PLGA component in the combination groups (co-spun through gradient + rings) were preserved longer with the support of the intertwined or underlying PCL, as evident by a translucent layer at weeks 3 through 6 in bilayer and gradient + rings images. Sample degradation for other analyses followed a similar trend, where the PLGA-only scaffolds were completely degraded by 3 weeks.
Fiber morphology
The average fiber diameter of the scaffolds ranged from 1.5-6.3 μm across groups (table 1) . There was a distinct difference between the PCL and PLGA fiber appearance and diameters. The PCL fibers (PCL-only and bilayer) had four fold smaller diameter fibers than the PLGA fibers (PLGA-only) at week 0 (p < 0.05). In addition, the PLGA fibers had a smoother, flatter surface with junctions between fibers deformed and fused together, while the PCL fibers were distinctly separate (figure 3).
As the scaffold degraded, the PLGA component completely degraded after week 0 (in PLGA-only and bilayer), lost its fibrous appearance and become an amorphous mass (gradient), or retained its fibrous appearance up to week 12 (gradient + rings). In the cases of blending or combining fiber types (co-spun and blended), the fiber morphology was unique. Co-spun fiber morphology became more irregular and distorted as the sample degraded (week 6) and regained a normal fibrous morphology at the final time point (week 12). Blend fibers had a unique morphology upon degradation, where the length of a single fiber transitioned between one large diameter fiber to a bundle of smaller fibers (week 6 and 12).
The sample cross-sections at week 0 revealed a fibrous cross-section in all groups, except for PLGAonly, which appeared to be more of a porous polymer mass. The layered scaffolds had a noticeable demarca-tion, indicating a transition between polymer types (bilayer, gradient, and gradient + rings).
Polymer degradation
The mass loss data analysis shows the change in mass over degradation time (figure 4). All groups experienced significant mass loss except for PCL-only, which was expected due to the slow degradation of PCL. For the co-spun, blended, bilayer, gradient, and gradient + rings groups, the mass loss dropped off significantly after 3 weeks, which was attributed to the degradation of the PLGA component. The blended and mixed scaffolds (co-spun and blended) experienced similar mass loss. Gradient scaffolds had the largest mass loss, while gradient + rings, a similar group with the exception of a PCL ring, had a much lower mass loss. This was expected since the PCL component was preserved over 12 weeks and comprised a larger part of the mass of the gradient + rings samples. No statistically significant differences were derived from these data.
The PCL component of the scaffolds in all groups maintained a similar molecular weight over the 12 week degradation (figure 5). The pure PCL scaffold (PCL-only) group had a consistent profile, maintaining a molecular weight around 117 kDa (MALS) or 146 kDa (RI). In contrast, the other treatment groups had molecular weight profiles that varied slightly more over time with a reduction in molecular weight at week 0 in the RI data, which could be due to PLGA and PCL chromatogram overlap thus reducing the M w at week 0. The co-spun group degraded to a larger extent than any of the other groups.
The PLGA profile revealed that the molecular weight significantly decreased over 12 weeks (figure 5). The pure PLGA scaffolds (PLGA-only) exhibited a rapid decrease from 64 kDa at 0 weeks to 6.5 kDa at 2 weeks (MALS) or 65.9 kDa at 0 weeks to 4.3 kDa at 2 weeks (RI). While processing the PLGA SEC data, it was difficult to distinguish between the PLGA and PCL at 0 weeks, so no data were collected for combination scaffolds at week 0. In the MALS profile, measurable PLGA was retained for 6 weeks in the Blend group, for 4 weeks in bilayer, gradient, and gradient + rings groups, and for 3 weeks in the cospun group. In the RI profile, measurable PLGA was retained for 6 weeks in all co-spun, blend, and gra- 
Note: PPCL fibers (PCL-only and bilayer groups) were smaller than PLGA fibers (PLGA-only group) at week 0 (denoted by * and ^, p = 0.05).
dient groups, for 4 weeks in the bilayer group, and only 2 and 4 week data points for the gradient + rings group. The dispersity (Ð) of the PCL component remained in the moderate polydisperse (Ð = 1.1-2.0) range for a majority of the groups across the degradation time points (table 2) . The exceptions to this moderate polydispersity include: week 0 samples in the co-spun, blend, bilayer, and gradient groups; week 1 samples in the blend, gradient, and gradient + rings group; and the week 12 samples in the co-spun group all exhibited broad polydispersity (Ð > 2.0). It is also important to note that nondegraded PCL had a Ð of 1.677 ± 0.008 and its Ð did not change during the 12 week degradation (in the PCL-only group).
The dispersity (Ð) of the PLGA component had a more variable profile as compared to the PCL component (table 2) . 52% of all samples remained in the moderate polydisperse range, while 44% of all samples were in the broad polydisperse range (4% were narrow monodisperse). Broad polydispersity occurred primarily in the later degradation time points: week 1 samples in the Gradient group; week 2 samples in PLGA-only, co-spun, bilayer, and gradient groups; week 3 and 4 samples in the co-spun, blend, and gradient groups. It is important to note that nondegraded PLGA had a Ð of 1.68 ± 0.06 and it became increasingly more polydisperse during degradation (in the PLGA-only group).
Porosity
Calculated porosity values revealed that the percent porosity significantly increased by 17-31% from 0 to 6 weeks for all groups (p < 0.05), except for PCL-only and gradient + rings (figure 6). The porosity remained in the same range from 6 to 12 weeks for all groups (no week 6 or 12 data for PLGA-only).
At 0 weeks, all groups had porosities in the range of 55-70% except for the PLGA-only group. PLGAonly had the lowest porosity of all other groups at the week 0 (p < 0.05). The gradient scaffolds had a 130% Weight-average molecular weight (M w ) for all retained scaffolds. MALS and RI data followed similar trends, with a decrease in molecular weight of PLGA containing groups up to 6 weeks. PCL and PLGA chromatography peaks were differentiated by retention time, with slight overlap at 0 weeks. Data represent means and error bars represent one standard deviation (n = 3).
higher porosity at week 12, as compared to the PCLonly group at week 12 (p < 0.05).
Mechanical properties
Tensile testing Stress-strain curves were linear through the tensile pull to 15% strain. The Young's modulus data showed that gradient + rings scaffolds outperformed other groups by 5-250-fold (p < 0.05), except for PCL-only and bilayer samples at week 0 (p < 0.05) (figure 7).
The equilibrium modulus was used to evaluate viscoelasticity of the scaffolds, by determining how much the scaffolds relaxed during a hold at constant strain. The equilibrium modulus data followed trends similar to the Young's modulus data where the gradient + rings samples outperformed all of the other groups (3-fold improvement over the PCL-only and bilayer group) (p < 0.05) (figure 7). Within the groups, the Young's moduli and equilibrium moduli did not significantly change over time. Table 2 . Polymer dispersity (Ð) values were categorized into uniform monodisperse (Ð = 1), narrow monodisperse (Ð = 1.0-1.1), moderate polydisperse (Ð = 1.1-2.0), and broad polydisperse (Ð > 2.0). 
Note: PCL and PLGA were moderately polydisperse and that dispersity increased with degradation time in the PLGA portion of the scaffolds. Figure 6 . Porosity (%) of scaffolds. Scaffolds increased in porosity over time, with the PLGA-only group being the least porous ($ denotes significantly smaller porosity than all other groups, p < 0.05). The gradient + rings group decreased in porosity with time, due to the remaining PCL rings (@ denotes significant porosity decrease from all other groups, p < 0.05). PCL-only scaffolds were less porous than the gradient scaffolds at week 12 (denoted by #, p < 0.05). Data represent means and error bars represent one standard deviation (n = 3).
Burst pressure
All of the scaffolds reached the maximum pressure of 30 psig without failure except for the Blend group at week 12. The mean burst pressure of the week 12 Blend was approximately 19.7 psig. The change in scaffold diameter was measured from beginning of testing to the end of testing and a trend was observed across all groups in which the average change in diameter increased with degradation time (figure 8). No statistically significant differences were established.
Suture retention
Suture pull-out testing results had an overall general trend of decreasing suture holding capacity (SHC) (data not presented) and SRS over degradation time ( figure 9 ). The direction of testing (circumferential and longitudinal) did not affect SHC or SRS. SRS data for circumferential direction revealed that within groups, blend SRS decreased by 97% from 0 to week 3, 96% to week 6, and 99% to week 12 (p < 0.05). Gradient SRS also had a degradation dependent decline in SRS (~66%) from week 0 to week 3 (p < 0.05). Between groups, PCL-only, week 12 SRSs were 2-fold or 400-fold higher than co-spun and blend scaffolds at week 12, respectively (p < 0.05). PLGA-only SRSs at week 0 were lower than all groups at week 0 (p < 0.05). PCL-only, bilayer, and gradient + rings SRSs at week 3 were 23-35 times larger than blend, week 3 SRSs (p < 0.05). PCL-only, bilayer, gradient, and gradient + rings SRSs at week 6 were 19-25 times larger than blend, week 6 SRSs (p < 0.05). Gradient + rings, week 12 SRSs were 2.4 times higher than co-spun at week 12 (p < 0.05).
Analysis of the SRS data in the longitudinal direction revealed that within groups, blend and gradient scaffolds were affected by degradation with the SRS decreasing by 22-fold or four fold, respectively over time (blend, week 0-week 6 and week 0-week 12; gradient, week 0-week 3) (p < 0.05). Among groups, PCL-only and Gradient + Rings, week 12 SRSs were 3-300 times greater SRSs than co-spun and blend at week 12 (p < 0.05). PLGA-only, week 0 SRS were lower than blend, bilayer, and gradient at week 0 (p < 0.05).
Tube flattening
The load required to flatten the scaffolds followed an overwhelming trend, where gradient + rings scaffolds outperformed (6-62 times higher) all other groups at corresponding time points (p < 0.05) (figure 10). Degradation had no significant impact on tube flattening force within the groups.
The recovery of scaffolds after flattening revealed that co-spun and blend scaffolds at 3, 6, and 12 weeks remained in a flatter state (or recovered 80-87% less) than PCL-only, bilayer, gradient, and gradient + rings at the corresponding time points (p < 0.05). Gradient + rings scaffolds at week 0 recovered 37-40% better than co-spun and blend at week 0 (p < 0.05). The blending or co-spinning of polymers resulted in tubular scaffolds that deformed to a greater extent than other groups.
Within the groups, PCL-only, week 0 scaffolds recovered less than at week 6 (p < 0.05). Co-spun, week 0 scaffolds recovered better than week 6 (p < 0.05). Blend, week 0 scaffolds recovered better than week 6 and week 12 (p < 0.05). Degradation of the blended or co-spun groups drastically reduced the scaffolds' ability to recover, as compared to other groups.
Discussion
This is the first time a novel trachea patch was designed and characterized, with a comparison of several versions of the patch being presented to determine the optimal scaffold design (table 3) .
The PLGA and PCL degradation, including mass loss and molecular weight, followed similar trends to published data. PLGA microspheres (50:50; inherent viscosity 0.32-0.44 dl g −1 ) showed erosion after 10 d and agglomeration into a polymeric mass by day 20 [17] . Semicrystalline PLLA copolymerized with 25% glycolide had a degradation half-life of 3 weeks [18] . We can thus postulate that PLGA used in the current study, with a 50% glycolide content and amorphous form of lactide, PDLA, would have a shorter half-life and our experimentation revealed this to be true. PCL's degradation profile did not change over the 12 weeks, as expected. PCL has been shown to maintain it's shape and molecular weight up to 2 years in vitro and in rats [19] .
Fiber diameter, pore size, porosity, and their interconnected relationship affect cell response. Submicron PCL fibers, in a range from 0.25-2 μm have been shown to improve cell attachment and proliferation due to the increased surface area that enhanced protein binding [20] . However, this relationship has not been seen with other polymers [20] . The scaffolds in the current study exhibited fiber diameters in the micron range, with PCL-only scaffolds exhibiting a slightly lower fiber diameter than other groups. Fiber morphology and diameter can be tuned with the electrospinning fabrication process (e.g. solution concentration, solution conductivity, needle to collector distance, ambient conditions) [21] . In our process, these parameters were empirically selected to produce uniform submicronmicron fibers in the range of 0.5-1.5 μm (data not shown). However, fiber morphology altered significantly after sterilization, specifically in the case of PLGA Figure 8 . Diameter change during burst pressure testing. As scaffolds degraded, the diameters deformed (mm) more in response to the catheter balloon inflation. At week 0, scaffolds resisted deformation, except for PLGA-only. No statistically significant differences were present. Data represent means and error bars represent one standard deviation (n = 3).
fibers, which appeared to have melted after sterilization (flattened appearance in SEM images). This phenomenon is not mentioned greatly in the electrospinning literature, except for one study that found that ethylene oxide can damage fragile structures found in electrospun materials [22] . Further investigation is needed to determine how the ethylene oxide sterilization process can be altered (e.g. concentration, temperature, humidity, time) to preserve scaffold architecture or to determine better sterilization methods.
The blending of two polymers prior to electrospinning created a distinctive fiber morphology which could be due to phase separation where the two polymers assumed distinct spatial organization with-in one fiber when electrospun, where the PCL component could be the spindle-like fibers in the interior of the fibers and the PLGA component filling around through PCL fibers. The difference in polymer properties (e.g. conductivity) could have affected how the two polymers electrospun together. The unique fiber morph ology created by polymer blending could be used beneficially in specific tissue applications.
Porosity is another important factor that affects cell infiltration and diffusion [23] . All of the groups, Figure 9 . SRS of scaffolds. Data represent means and error bars represent one standard deviation (n = 3). Circumferential and longitudinal testing simulated suture pull-out in the circumferential and longitudinal directions when implanted in a trachea. In the circumferential direction: SRS decreased from 0 to week 3, week 6, and week 12 (denoted by ^, p < 0.05), Gradient SRS also had degradation dependent decline in SRS from week 0 to week 3 (denoted by ^, p < 0.05), PCL-only, week 12 SRS were higher than cospun and blend scaffolds at week 12 (denoted by $, p < 0.05), PLGA-only, week 0 SRS were lower than all groups at week 0 (denoted by * , p < 0.05), blend, week 3 SRS were lower than PCL-only, bilayer, and gradient + rings at week 3 (denoted by +, p < 0.05), Blend, week 6 SRS were lower than PCL-only, bilayer, gradient, and gradient + rings at week 6 (denoted by ?, p < 0.05), and gradient + rings, week 12 SRS were higher than co-spun at week 12 (denoted by =, p < 0.05). In the longitudinal direction: blend and gradient scaffolds were affected by degradation with the SRS decreasing over time (blend, week 0-week 6 and week 0-week 12; gradient, week 0-week 3) (denoted by ^, p < 0.05), PCL-only and gradient + rings, week 12 had greater SRS than co-spun and blend at week 12 (denoted by $ and %, p < 0.05), and PLGA-only, week 0 SRS were lower than blend, bilayer, and gradient at week 0 (denoted by #, p < 0.05).
except for the PLGA-only group, at some point during degradation had the recommended range of 70-90% porosity [20] . All groups became significantly more porous after 6 weeks due to the degradation of the PLGA component. The gradient + ring group had a decline in porosity due to the retention of the solid PCL ring. To obtain more accurate porosity measurement, other techniques could be employed (e.g. gas adsorption or flow porosimetry) [24] , although our work with microCT revealed that the submicron pore sizes in electrospun materials were not detectable [25] . Techniques to increase porosity can be employed with electrospinning, such as salt leaching, sacrificial-fiber incorporation, 3D printing, or phase separation [25] .
The PCL ring's porosity could be increased to allow for cellular infiltration prior to degradation; however, mechanical properties would need to be maintained with any increase in porosity.
Analysis of the polymer dispersity revealed that the starting PCL and PLGA were moderately polydisperse and that dispersity increased with degradation time in the PLGA portion of the scaffolds. This polydispersity indicates that the mode of PLGA degradation in our study was hydrolysis through a chain-end scission mechanism rather than cleavage of the ester bonds within the polymer chain. Environmental pH has been shown to influence this hydrolysis mechanism, where acid environments result in a random scission and basic Figure 10 . Tube flattening and recovery. Data represent means and error bars represent one standard deviation (n = 3). The load required to flatten the scaffolds followed an overwhelming trend, where gradient + rings scaffolds outperformed all other groups at corresponding time points (denoted by #, p < 0.05). The recovery of scaffolds after flattening revealed that co-spun and blend scaffolds at 3, 6, and 12 weeks remained in a flatter state (or recovered less) than PCL-only, bilayer, gradient, and gradient + rings at the corresponding time points (denoted by * , p < 0.05). Gradient + Rings scaffolds at week 0 recovered better than Co-spun and blend at week 0 (denoted by = &, p < 0.05). PCL-only, week 0 scaffolds recovered less than at week 6 (denoted by !, p < 0.05). The reason for this may be due to measurement error or variability in scaffold properties or geometry. Co-spun, week 0 scaffolds recovered better than week 6 (denoted by #, p < 0.05). Blend, week 0 scaffolds recovered better than week 6 and week 12 (denoted by #, p < 0.05).
environments result in a sequential cleavage from the chain end [26] .
Molecular weight change and mass loss of the scaffolds were used to assess how the tunable properties (i.e. polymer mixing and layering) affect degradation. Since static degradation conditions were employed, as compared to dynamic mechanical loading, chemical degradation was the primary degradation mechanism. PCL and PLGA degrade through hydrolysis of the aliphatic ester linkages and undergo bulk erosion [27] . We hypothesized that fiber mixing (co-spun, gradient, and gradient + rings) would slow PLGA degradation due to limited diffusion of water to the internalized PLGA fibers. Indeed, the molecular weight profile for PLGA was slightly higher in combination groups as compared to PLGA-only (variation in M w in MALS data due to signal overlap). The decrease in PLGA molecular weight had a direct impact on SRS, and less so on tensile or compressive properties. The dispersion of PLGA throughout the bulk of the scaffold (blend and co-spun) resulted in worsened tube flattening recovery, indicating that a thick PCL layer contributed to the elastic recovery of the scaffolds. Should the mechanical or drug delivery properties need to be tailored, the degradation of the PLGA can be controlled by LA/GA ratio, molecular weight, and shape/structure of matrix.
Desired mechanical properties for scaffolds usually rely on mimicking physiological conditions or empirical data derived from native tissue, although biomimicry may not necessarily result in functional in vivo performance. Tensile properties in the circumferential direction have no analog in vivo, besides inhalation/exhalation force, which will be discussed in the burst pressure section. Tracheal cartilage, crucial to the structural integrity of the trachea, exhibits a nonlinear stress-stain behavior with tensile forces from 0.02 to 0.01 N (porcine cartilage) [28] . The superficial zone of human tracheal cartilage (collagen dense region) resists tension, while the inner layer (proteoglycan rich) resists compression (equilibrium tensile modulus was 13.6 ± 1.5 MPa for abluminal superficial zone and 4.6 ± 1.7 MPa for middle zone) [29] . Rabbit tracheal cartilage exhibits an ultimate tensile strength of 4.08 ± 0.96 × 10 2 kPa and elastic modulus of 3.5 ± 1.1 × 10 2 kPa [30] . Comparing these data to our data, our scaffolds exceeded the Young's modulus of the native rabbit trachea, except for the PLGA-only group. Gradient + rings scaffolds possessed an equilibrium modulus similar to human tracheal tissue in the abluminal superficial zone.
Physiological expiration and inspiratory pressures for adults and children are in the range of 60-150 mm Hg (or 0.853-2.133 psig) [31] . Intratracheal gauge pressure during coughing has been reported to be 90 mmHg (or 1.74 psig) [32] . Bursting strength of the porcine trachea has been reported to be 180 mmHg (3.48 psig) in the pharyngeal portion (dorsal or top of trachea) and progressively decreased down the trachea length to 110 mmHg (2.13 psig) in the tracheal carina (ventral or bottom of trachea before bifurcation) [33] . Our implant was tested in its tubular form, not sutured into a native trachea. Testing the implant alone revealed that the scaffolds in all of the groups far exceeded any forces exerted by breathing or pressures required to burst native porcine tracheas. If more complex characterization were to be employed, dynamic degradation conditions could mimic breathing forces and would likely speed degradation of the scaffolds thus altering mechanical properties [34] . In vivo, if any failure occurred it would likely be at the suture line, thus future testing could involve testing the scaffolds sutured into cadaveric tracheas.
Suture retention is crucial as failure at the suture line would be catastrophic. Maximum suture retention in an anastomosis model using a single-interrupted PDS suture, placed around the circumference of the trachea, was 123 N (sheep trachea) [35] . Native trachea suture retention for our testing method was not found in the literature. Our suture holding capacities were at a much lower range than an anastomosis model, due to the inequivalent comparison of one single-interrupted suture (our testing) to a series of single-interrupted sutures (anastomosis model). The PLGA-only and blend groups had poor SRSs, while the other groups performed in a range of 20-70 MPa. Tube flattening or radial compression of the trachea is comparable to a situation where an external force compressed the airway (i.e. during trauma). Porcine tracheas withstand compression (across the diameter) to 50% strain, which results in a mean radial pedestal force of 10 N [33] . The rabbit trachea had a compressive strength of 2.1 N at 50% compressive displacement [36] . Our scaffolds were tested to 100% strain (completely flattened), with that in mind, our gradient + rings scaffolds far exceeded the native porcine and rabbit tracheas' ability to resist radial force. The PCL-only and bilayer scaffolds had a mean tube flattening force of 3.8 N, which could be comparable to the rabbit trachea compressive strength. This tube flattening property of the scaffolds will be crucial to tracheal patches that exist for the purpose of holding open a stenosed trachea that has been opened to widen the airway.
The purpose of the co-spun versus blended groups was to determine if different mixing techniques would synergistically harness the PCL and PLGA properties. Co-electrospinning creates a mixture on the fiber-scale, while polymer blending creates a mixture on the molecular scale (while not synthesizing a new co-polymer). PCL is inexpensive and provides flexibility to the construct, while PLGA is expensive and has reduced mechanical properties (brittle and low elongation) [37] . PCL is more hydrophobic, thus cellular interaction is poor, while PLGA is more hydrophilic and has better cellular attachment and proliferation [37] . The current study showed that blending or co-spinning PLGA and PCL reduced the mechanical performance (i.e. tube flattening recovery and suture retention) as compared to scaffolds with PCL or PLGA alone or in a layered format.
In this application, maintaining an intact and airtight trachea takes precedence over matching tissue formation. A quality regenerative medicine approach should match biomaterial degradation to tissue formation, but premature degradation of a tracheal biomaterial could leave a hole in the airway which could be life threatening. The appropriateness of the degradation rate would be best determined by in vivo evaluation, and perhaps reducing degradation time in iterative future studies, but not losing sight of the quality of regeneration, sustaining life, and providing adequate mechanical performance.
The application of these materials will impact interpretation of the results. Tracheal materials can be implanted in small, patch-type defects and in long, circumferential defects. Each scenario demands slightly different properties of our scaffolds and should be considered when utilizing our data and materials. Additionally, these scaffolds could have other applications, specifically vascular and intestinal tissue engineering.
In conclusion, we evaluated the fiber morphology, polymer degradation, porosity, and mechanical properties of seven variations of our fibrous trachea scaffolds under degradation conditions. While all scaffolds had at least one favorable characteristic, the graded scaffolds with rings had improved tensile and radial compression properties, largely due to the 3D printed PCL rings, which will be important in vivo for holding a stenosed trachea open following surgical intervention. And we can assume that the rings would have an impact on burst pressure if testing could exceed 30 psig. The fibrous PCL component also plays an important role in recovery properties and suture retention, with the tensile equilibrium moduli and percent recovery after tube flattening being much higher in the PCL containing groups. Additionally, the fibrous materials are an excellent suture holding substrate making this scaffold easily implantable. We can conclude that the addition of a structural and flexible fibrous component is crucial to create a scaffold with trachea-like mechanical performance (e.g. airtight, prevent airway collapse), that is also easily moldable to the patient and off-the-shelf. Therefore, our reinforced, fibrous scaffolds have the potential to be utilized for trachea tissue engineering applications, after further in vitro and in vivo testing.
